IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis

In this interactive CME-certified video module Dafna D. Gladman MD FRCPC provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.

Share

Supporters

Lilly USA